US medical-device maker Medtronic will buy its Irish-based competitor Covidien for $42.9 billion, the company said.
The deal, announced late Sunday, would allow Medtronic to take advantage of Ireland's lower business tax rates -- 12.5 percent versus 35 percent in the United States.